Literature DB >> 19913120

Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation.

In-Sook Kwun1, Young-Eun Cho, Ria-Ann R Lomeda, Hong-In Shin, Je-Yong Choi, Young-Hee Kang, John H Beattie.   

Abstract

A characteristic sign of zinc deficiency is retarded skeletal growth, but the role of zinc in osteoblasts is not well understood. Two major events for bone formation include osteoblast differentiation by bone marker gene expression, which is mainly regulated by bone-specific transcription factor Runx2 and extracellular matrix (ECM) mineralization by Ca deposits for bone nodule formation. We investigated whether zinc deficiency down-regulates bone marker gene transcription and whether this might occur through modulation of Runx2. We also investigated whether zinc deficiency decreases ECM mineralization in osteoblastic MC3T3-E1 cells. In the presence of 5 mumol/L TPEN as zinc chelator, zinc deficiency (ZnD: 1 micromol Zn/L) decreased bone marker gene (collagen type I, osteopontin, alkaline phosphatase, osteoclacin and parathyroid hormone receptor) expression, as compared to normal osteogenic medium (OSM) or zinc adequate medium (ZnA: 15 micromol/L) (P<0.05) both at 5 days (proliferation) and 15 days (matrix maturation). Decreased bone marker gene transcription by zinc deficiency could be caused by decreased nuclear Runx2 protein (P=0.05) and transcript (P<0.05) levels in ZnD. Furthermore, within the first 24 h of differentiation when Runx2 expression is induced, maximal Runx2 mRNA and nuclear protein levels were delayed in ZnD compared to OSM and ZnA. ECM Ca deposition was also lower in ZnD, which was also indirectly confirmed by detection of decreased cellular (synthesized) and medium (secreted) ALP activity as well as matrix ALP activity. Taken together, zinc deficiency attenuated osteogenic activity by decreasing bone marker gene transcription through reduced and delayed Runx2 expression and by decreasing ECM mineralization through inhibition of ALP activity in osteoblasts. Decreased and delayed bone marker gene, Runx2 expression and ECM mineralization in osteoblasts by zinc deficiency can be a potential explanation for the retarded skeletal growth which is the major zinc deficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913120     DOI: 10.1016/j.bone.2009.11.003

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  23 in total

1.  Panax notoginseng stimulates alkaline phosphatase activity, collagen synthesis, and mineralization in osteoblastic MC3T3-E1 cells.

Authors:  Zhe Ji; Yizhao Cheng; Puwei Yuan; Xiaoqian Dang; Xiong Guo; Weizhuo Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-04-23       Impact factor: 2.416

2.  Enamel matrix derivative enhances the proliferation and osteogenic differentiation of human periodontal ligament stem cells on the titanium implant surface.

Authors:  Guang Li; Jing Hu; Hui Chen; Liang Chen; Na Zhang; Lisheng Zhao; Ning Wen; Yongjin Yang
Journal:  Organogenesis       Date:  2017-06-09       Impact factor: 2.500

3.  Enhanced cellular osteogenic differentiation on Zn-containing bioglass incorporated TiO2 nanorod films.

Authors:  Meng He; Xiaoyi Chen; Kui Cheng; Lingqing Dong; Wenjian Weng; Huiming Wang
Journal:  J Mater Sci Mater Med       Date:  2018-08-17       Impact factor: 3.896

4.  Cell apoptosis induced by zinc deficiency in osteoblastic MC3T3-E1 cells via a mitochondrial-mediated pathway.

Authors:  Baolei Guo; Maowei Yang; Dan Liang; Lei Yang; Junjun Cao; Le Zhang
Journal:  Mol Cell Biochem       Date:  2011-10-14       Impact factor: 3.396

5.  SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo.

Authors:  Gary Fielding; Susmita Bose
Journal:  Acta Biomater       Date:  2013-07-18       Impact factor: 8.947

6.  Effects of SiO2, SrO, MgO, and ZnO dopants in tricalcium phosphates on osteoblastic Runx2 expression.

Authors:  Gary A Fielding; Will Smoot; Susmita Bose
Journal:  J Biomed Mater Res A       Date:  2013-10-17       Impact factor: 4.396

7.  Development of orthophosphosilicate glass/poly(lactic acid) composite anisotropic scaffolds for simultaneous reconstruction of bone quality and quantity.

Authors:  Sungho Lee; Fukue Nagata; Katsuya Kato; Toshihiro Kasuga; Takayoshi Nakano
Journal:  J Biomed Mater Res A       Date:  2020-08-10       Impact factor: 4.396

8.  Characterization of adipose-derived stromal/stem cells from the Twitcher mouse model of Krabbe disease.

Authors:  Xiujuan Zhang; Julie A Semon; Shijia Zhang; Amy L Strong; Brittni A Scruggs; Jeffrey M Gimble; Bruce A Bunnell
Journal:  BMC Cell Biol       Date:  2013-04-16       Impact factor: 4.241

9.  The effect of Link N on differentiation of human bone marrow-derived mesenchymal stem cells.

Authors:  John Antoniou; Hong Tian Wang; Abdulrahman M Alaseem; Lisbet Haglund; Peter J Roughley; Fackson Mwale
Journal:  Arthritis Res Ther       Date:  2012-12-10       Impact factor: 5.156

10.  In vitro and in vivo evaluation of zinc-modified ca-si-based ceramic coating for bone implants.

Authors:  Jiangming Yu; Kai Li; Xuebin Zheng; Dannong He; Xiaojian Ye; Meiyan Wang
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.